Carcinoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Carcinoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) [Phase 2]
Phase 2 clinical trial results for pembrolizumab in patients with poor-prognosis carcinoma of unknown primary site.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cancer Genetic Testing in Ethnic Populations [NA]
A Mayo Clinic-sponsored clinical trial update on cancer genetic testing across multiple cancer types in diverse ethnic populations; the stud…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) [Phase 2]
Phase 2 clinical trial update for pembrolizumab in patients with carcinoma of unknown primary; the study is currently active but not recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Genomic Investigation of Unusual Responders
This clinical trial update describes a University Health Network study investigating genomic factors in unusual responders across multiple c…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers
This completed trial compares tissue- and liquid-biopsy biomarkers in Carcinoma of Unknown Primary (CUP) to evaluate diagnostic approaches.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS [Phase 3]
Phase 3 clinical trial update examining postoperative pain and hospital stay after transoral robotic surgery for squamous cell carcinoma of …
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary [Phase 2]
Phase 2 trial of pembrolizumab with concurrent radiation in previously treated carcinoma of unknown primary was terminated, with results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary [Phase 2]
Phase 2 trial update evaluating gemcitabine in patients with metastatic cancer of unknown primary.
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary [Phase 2]
Phase 2 clinical trial update on elective mucosal irradiation for head-and-neck cancer of unknown primary.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor [Phase 3]
Phase 3 study evaluating radiation therapy for metastases to neck lymph nodes from an unknown primary tumor; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
This entry provides an update on a clinical trial evaluating the use of PET scans and CT scans in patients with locally advanced head and ne…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [Phase 2]
Phase 2 clinical trial evaluating irinotecan followed by fluorouracil and leucovorin in patients with stage III/IV colorectal cancer, carcin…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary [Phase 2]
Phase 2 trial evaluating gemcitabine and irinotecan in carcinoma of unknown primary has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and everolimus in patients with previously untreated carcinoma of unknown primary. The stu…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated radiation therapy with combination chemotherapy and amifostine for head and neck cancer; the study has completed…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 clinical trial update evaluating treatments guided by molecular profiling for carcinoma of unknown primary site; the study has compl…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary [Phase 2]
Phase 2 study evaluating gemcitabine and docetaxel chemotherapy in patients with carcinoma of unknown primary.
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin [Phase 2]
Phase 2 trial evaluating gemcitabine, docetaxel, and capecitabine for carcinoma of unknown primary has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary [Phase 2]
Phase 2 trial comparing Belinostat, Carboplatin and Paclitaxel (BelCaP) to Carboplatin and Paclitaxel in carcinoma of unknown primary has co…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site [Phase 2]
A Phase 2 trial evaluating first-line therapy with paclitaxel/carboplatin in combination with bevacizumab and erlotinib for carcinoma of unk…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 trial evaluating oxaliplatin in combination with capecitabine for relapsed/refractory carcinoma of unknown primary site; the study i…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy for metastatic carcinoma of unknown primary.